Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Receivables (2019 - 2025)

InMed Pharmaceuticals has reported Change in Receivables over the past 5 years, most recently at -$159977.0 for Q4 2025.

  • For Q4 2025, Change in Receivables fell 606.46% year-over-year to -$159977.0; the TTM value through Dec 2025 reached -$77178.0, up 30.03%, while the annual FY2025 figure was $114690.0, 24.07% up from the prior year.
  • Change in Receivables for Q4 2025 was -$159977.0 at InMed Pharmaceuticals, down from -$122160.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $207019.0 in Q4 2023 and troughed at -$165188.0 in Q1 2024.
  • A 5-year average of $10230.4 and a median of $10198.0 in 2021 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 14451.57% in 2022 and fell as far as 2592.58% in 2022.
  • Year by year, Change in Receivables stood at -$638.0 in 2021, then soared by 14451.57% to $91563.0 in 2022, then skyrocketed by 126.09% to $207019.0 in 2023, then plummeted by 110.94% to -$22645.0 in 2024, then crashed by 606.46% to -$159977.0 in 2025.
  • Business Quant data shows Change in Receivables for INM at -$159977.0 in Q4 2025, -$122160.0 in Q3 2025, and $99715.0 in Q2 2025.